Bone Therapeutics stock analysis
Bone Therapeutics (0R55) Share Price & Analysis
0R55 Stock Chart & Stats
- Day’s Range
- EUR 0.01 - EUR 0.02
- 52-Week Range
- EUR 0.01 - EUR 0.02
- Previous Close
- EUR 0.01
- Volume
- N/A
- Average Volume (3M)
- 0
- Market Cap
- EUR 1.31M
- Enterprise Value
- EUR 3.78M
- Total Cash (Recent Filing)
- EUR 816.00K
- Total Debt (Recent Filing)
- EUR 26.79M
- Price to Earnings (P/E)
- 0.1
- Beta
- -0.01
- Next Earnings
- Apr 29, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Mar 15, 2022
- Dividend Yield
- N/A
Bone Therapeutics News
0R55 FAQ
What was Bone Therapeutics’s price range in the past 12 months?
What is Bone Therapeutics’s market cap?
When is Bone Therapeutics’s upcoming earnings report date?
How were Bone Therapeutics’s earnings last quarter?
Is Bone Therapeutics overvalued?
Does Bone Therapeutics pay dividends?
What is Bone Therapeutics’s EPS estimate?
How many shares outstanding does Bone Therapeutics have?
What happened to Bone Therapeutics’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Bone Therapeutics?
What is the TipRanks Smart Score and how is it calculated?
Company Description
Bone Therapeutics
BioSenic S.A., a biotechnology company located in Mont-Saint-Guibert, Belgium, is dedicated to progressing clinical therapeutic solutions. The firm utilizes two primary technology platforms: an innovative allogeneic cell and gene therapy system featuring distinct bone marrow-derived mesenchymal stromal cells designed for convenient on-site hospital storage; and an Arsenic Trioxide platform. The latter is deployed in immuno-oncology to target illnesses such as graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's leading experimental drug, ALLOB, is currently undergoing a Phase IIb clinical trial for patients with complicated tibial fractures.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Jean-Luc Vandebroek
- Employees
- 12
- Website
- www.biosenic.com
- Address
- Building H (box 24), Mont-Saint-Guibert, 1435, BE
Bone Therapeutics (0R55) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 3 | 6 |
| Technical Analysis | 4 | 1 | 0 |
| Moving Averages | 2 | 2 | 6 |


